Clinical Trials Browser

OTHER × Lymphoma, Follicular × utomilumab × Clear all

NCT03636503 2025-02-06

Rituximab + Immunotherapy in Follicular Lymphoma

Phase 1 Terminated

24 enrolled 25 charts

Lymphoma, Lymphoma, Follicular